Suicide and the polyamine system

CNS and Neurological Disorders - Drug Targets

Volumn 12, Issue 7, 2013, Pages 980-988

  Gross, Jeffrey A ^a   Turecki, Gustavo ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Epigenetics; Major depressive disorder; Neurobiology; Polyamine stress response; Polyamines; Spermidine spermine N1 acetyltransferase; Suicide

Indexed keywords

AGMATINE; ANTIZYME; CHOLINERGIC RECEPTOR; DEXAMETHASONE; IMIDAZOLINE RECEPTOR; LITHIUM; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROTRANSMITTER; ORNITHINE DECARBOXYLASE; POLYAMINE; PUTRESCINE; SEROTONIN RECEPTOR; SPERMIDINE; SPERMINE; SPERMINE SYNTHASE;

ANXIETY; BIOSYNTHESIS; CENTRAL NERVOUS SYSTEM; GENE EXPRESSION; HUMAN; MAJOR DEPRESSION; MOOD DISORDER; NONHUMAN; REVIEW; STRESS; SUICIDE;

BIOGENIC POLYAMINES; BRAIN; FORECASTING; GENE EXPRESSION; HUMANS; MENTAL DISORDERS; SUICIDE;

EID: 84889001629     PISSN: 18715273     EISSN: 19963181     Source Type: Journal    
DOI: 10.2174/18715273113129990095     Document Type: Review

References (72)

1. Arsenault-Lapierre, G.; Kim, C; Turecki, G. Psychiatric diagnoses in 3275 suicides: a meta-analysis. BMC Psychiatry, 2004, 4, 37.
2. Nock, M.K.; Borges, G; Bromet, E.J.; Cha, C.B.; Kessler, R.C.; Lee, S. Suicide and suicidal behavior. Epidemiol. Rev., 2008, 30, 133-154.
3. Ernst, C; Mechawar, N.; Turecki, G. Suicide neurobiology. Prog. Neurobiol, 2009, 89, 315-333.
4. Turecki, G.; Ernst, C; Jollant, R; Labonte, B.; Mechawar, N. The neurodevelopmental origins of suicidal behavior. Trends Neurosci., 2012, 35, 14-23.
5. Fiori, L.M.; Bureau, A.; Labbe, A.; Croteau, I; Noel, S.; Merette, C; Turecki, G. Global gene expression profiling of the polyamine system in suicide completers. Intl. J. Neuropsychopharmacol, 2011, 14(5), 595-605.
6. Sequeira, A; Gwadry, F.G; Ffrench-Mullen, J.M.; Canetti, L.; Gingras, Y.; Casero, RA, Jr.; Rouleau, G.; Benkelfat, C; Turecki, G. Implication of SSAT by gene expression and genetic variation in suicide and major depression. Arch. Gen. Psychiatry, 2006, 63, 35-48.
7. Fiori, L.M.; Mechawar, N.; Turecki, G. Identification and characterization of spermidine/spermine Nl-acetyltransferase promoter variants in suicide completers. Biol. Psychiatry, 2009, 66, 460-467.
8. Fiori, L.M.; Turecki, G. Epigenetic regulation of spermidine/spermine N(l)-acetyltransferase (SAT1) in Suicide. J. Psychiatric Res., 2011, 45, 1229-1235.
9. Tabor, C.W.; Tabor, H. Polyamines. Annu. Rev. Biochem., 1984, 53, 749-790.
10. Bastida, CM.; Cremades, A.; Castells, M.T.; Lopez-Contreras, A.J.; Lopez-Garcia, C; Sanchez-Mas J, Penafiel R Sexual dimorphism of ornithine decarboxylase in the mouse adrenal: influence of polyamine deprivation on catecholamine and corticoid levels. Am. J. Physiol. Endocrinol. Metab., 2007, 292, E1010-E1017.
11. Ritz, M.C.; Mantione, C.R.; London, E.D. Spermine interacts with cocaine binding sites on dopamine transporters. Psychopharmacology, 1994, 114, 47-52.
12. Gilad, G; Gilad, V.H.; Wyatt, RJ. Polyamines modulate the binding of GABAA-benzodiazepine receptor ligands in membranes from the rat forebrain. Neuropharmacology, 1992, 31, 895-898.
13. de Vera, N.; Martinez, E.; Sanfeliu, C. Spermine induces cell death in cultured human embryonic cerebral cortical neurons through N-methyl-D-aspartate receptor activation. J. Neurosci. Res., 2008, 86, 861-872.
14. Galea, E.; Regunathan, S.; Eliopoulos, V.; Feinstein, D.L.; Reis, D.J. Inhibition of mammalian nitric oxide synthases by agmatine, an endogenous polyamine formed by decarboxylation of arginine. Biochem. J., 1996, 316(Pt 1), 247-249.
15. Reis, D.J.; Regunathan, S. Is agmatine a novel neurotransmitter in brain? Trends Pharmacol. Sci., 2000, 21, 187-193.
16. Williams, K. Modulation and block of ion channels: a new biology of polyamines. Cell. Signal., 1997, 9, 1-13.
17. Krauss, M.; Langnaese, K.; Richter, K.; Brunk, I.; Wieske, M.; Ahnert-Hilger, G.; Veh, RW.; Laube, G. Spermidine synthase is prominently expressed in the striatal patch compartment and in putative interneurones of the matrix compartment. J. Neurochem., 2006, 97, 174-189.
18. Otake, K.; Ruggiero, D.A.; Regunathan, S.; Wang, H.; Milner, T.A; Reis, D.J. Regional localization of agmatine in the rat brain: an immunocytochemical study. Brain Res., 1998, 787, 1-14.
19. Diler, AS.; Ziylan, Y.Z.; Uzum, G; Lefauconnier, J.M.; Seylaz, I; Pinard, E. Passage of spermidine across the blood-brain barrier in short recirculation periods following global cerebral ischemia: effects of mild hyperthermia. Neurosci. Res., 2002, 43, 335-342.
20. Seiler, N. Polyamine metabolism and function in brain. Neurochem. Intl., 1981, 3, 95-110.
21. Piletz, J.E.; May, P.J.; Wang, G; Zhu, H. Agmatine crosses the blood-brain barrier. Ann. NY Acad. Sci., 2003, 1009, 64-74.
22. Feng, Y.; Piletz, J.E.; Leblanc, M.H. Agmatine suppresses nitric oxide production and attenuates hypoxic-ischemic brain injury in neonatal rats. Pediat. Res., 2002, 52, 606-611.
23. Luszczki, J.J.; Czernecki, R; Wojtal, K.; Borowicz, K.K.; Czuczwar, S.J. Agmatine enhances the anticonvulsant action of phenobarbital and valproate in the mouse maximal electroshock seizure model. J. Neural Transm., 2008, 115, 1485-1494.
24. Gibson, D.A; Harris, B.R.; Rogers, D.T.; Littleton, J.M. Radioligand binding studies reveal agmatine is a more selective antagonist for a polyamine-site on the NMDA receptor than arcaine or ifenprodil. Brain research 2002, 952, 71-77.
25. Li, Y.F.; Gong, Z.H.; Cao, IB.; Wang, H.L.; Luo, Z.P.; Li, J. Antidepressant-like effect of agmatine and its possible mechanism. Eur. J. Pharmacol, 2003, 469, 81-88.
26. Gong, Z.H.; Li, Y.F.; Zhao, N.; Yang, H.J.; Su, R.B.; Luo, Z.P.; Li, J. Anxiolytic effect of agmatine in rats and mice. Eur. J. Pharmacol, 2006, 550, 112-116.
27. Taksande, B.G; Kotagale, N.R; Tripathi, S.J.; Ugale, RR; Chopde, C.T. Antidepressant like effect of selective serotonin reuptake inhibitors involve modulation of imidazoline receptors by agmatine. Neuropharmacology, 2009, 57, 415-424.
28. Genedani, S.; Saltini, S.; Benelli, A.; Filaferro, M.; Bertolini, A. Influence of SAMe on the modifications of brain polyamine levels in an animal model of depression. Neuroreport, 2001, 12, 3939-3942.
29. Zomkowski, A.D.; Santos, A.R.; Rodrigues, AL. Putrescine produces antidepressant-like effects in the forced swimming test and in the tail suspension test in mice. Prog. Neuropsychopharmacol. Biol. Psychiatry, 2006, 30, 1419-1425.
30. Guipponi, M.; Deutsch, S.; Kohler, K.; Perroud, N.; Le Gal, F.; Vessaz, M.; Laforge, T.; Petit, B.; Jollant, F.; Guillaume, S.; Baud, P.; Courtet, P.; La Harpe, R; Malafosse, A. Genetic and epigenetic analysis of SSAT gene dysregulation in suicidal behavior. Am. J. Med. Genet. Part B Neuropsychiatric Genet, 2009, 150B, 799-807.
31. Fiori, L.M.; Turecki, G. Association of the SAT1 in/del polymorphism with suicide completion. Am. J. Med. Genet. Part B Neuropsychiatric Genet, 2010, 153B, 825-829.
32. Klempan, T.A.; Rujescu, D.; Merette, C; Himmelman, C; Sequeira, A.; Canetti, L.; Fiori, L.M.; Schneider, B.; Bureau, A; Turecki, G. Profiling brain expression of the spermidine/spermine Nl-acetyltransferase 1 (SAT1) gene in suicide. Am. J. Med. Genet. Part B Neuropsychiatric Genet, 2009, 150B, 934-943.
33. Karssen, A.M.; Her, S.; Li, J.Z.; Patel, P.D.; Meng, F.; Bunney, W.E., Jr.; Jones, E.G.; Watson, S.J.; Akil, H.; Myers, RM.; Schatzberg A.F.; Lyons, D.M. Stress-induced changes in primate prefrontal profiles of gene expression. Mol. Psychiatry, 2007, 12, 1089-1102.
34. Perera, T.D.; Dwork, A.J.; Keegan, K.A.; Thirumangalakudi, L.; Lipira, CM.; Joyce, N.; Lange, C; Higley, J.D.; Rosoklija, G.; Hen, R; Sackeim, H.A.; Coplan, J.D. Necessity of hippocampal neurogenesis for the therapeutic action of antidepressants in adult nonhuman primates. PloS One, 2011, 6, el7600.
35. Kurian, L.; Palanimurugan, R.; Godderz, D.; Dohmen, R.J. Polyamine sensing by nascent ornithine decarboxylase antizyme stimulates decoding of its mRNA. Nature, 2011, 477, 490-494.
36. Palanimurugan, R.; Scheel, H.; Hofmann, K.; Dohmen, RJ. Polyamines regulate their synthesis by inducing expression and blocking degradation of ODC antizyme. EMBO J., 2004, 23, 4857-4867.
37. Papakostas, G.I.; Mischoulon, D.; Shyu, I.; Alpert, J.E.; Fava, M. S-adenosyl methionine (SAMe) augmentation of serotonin reuptake inhibitors for antidepressant nonresponders with major depressive disorder: a double-blind, randomized clinical trial. Am. J. Psychiatry, 2010, 767, 942-948.
38. Fiori, L.M.; Turecki, G. Implication of the polyamine system in mental disorders. J. Psychiatry Neurosci. JPN, 2008, 33, 102-110.
39. Dumais, A.; Lesage, A.D.; Alda, M.; Rouleau, G.; Dumont, M.; Chawky, N.; Roy, M.; Mann, J.J.; Benkelfat, C; Turecki, G. Risk factors for suicide completion in major depression: a case-control study of impulsive and aggressive behaviors in men. Am. J., Psychiatry, 2005, 762, 2116-2124.
40. Lesage, A.D.; Boyer, R; Grunberg, F.; Vanier, C; Morissette, R; Menard-Buteau, C; Loyer, M. Suicide and mental disorders: a case-control study of young men. Am. J. Psychiatry, 1994, 757, 1063-1068.
41. Turecki, G. Dissecting the suicide phenotype: the role of impulsive-aggressive behaviours. J. Psychiatry Neurosci. JPN, 2005, 30, 398-408.
42. Das, I.; Ramchand, C.N.; Gliddon, A.; Hirsch, S.R. Nitric oxide, free radicals and polyamines may have a role in the membrane pathology of schizophrenia. Neuropsychobiology, 1998, 37, 65-67.
43. Gilad, G.M.; Gilad, V.H.; Casanova, M.F.; Casero, R.A., Jr. Polyamines and their metabolizing enzymes in human frontal cortex and hippocampus: preliminary measurements in affective disorders. Biol. Psychiatry, 1995, 38, 227-234.
44. Gilad, G.M.; Gilad, V.H. Polyamines in neurotrauma. Ubiquitous molecules in search of a function. Biochem. Pharmacol, 1992, 44, 401-407.
45. Gilad, G.M.; Gilad, V.H. Overview of the brain polyamine-stress-response: regulation, development, and modulation by lithium and role in cell survival. Cell. Mol Neurobiol, 2003, 23, 637-649.
46. Gilad, G.M.; Gilad, V.H.; Wyatt, R.J.; Casero, R.A., Jr. Chronic lithium treatment prevents the dexamethasone-induced increase of brain polyamine metabolizing enzymes. Life Sci., 1992, 50, PL149-154.
47. Gilad, G.M.; Gilad, V.H.; Casero, R.A., Jr. Lithium exerts a time-dependent and tissue-selective attenuation of the dexamethasone-induced polyamine response in rat brain and liver. Brain Res., 1994, 636, 187-192.
48. Wang, Y.; Devereux, W.; Stewart, T.M.; Casero, R.A., Jr. Characterization of the interaction between the transcription factors human polyamine modulated factor (PMF-1) and NF-E2-related factor 2 (Nrf-2) in the transcriptional regulation of the spermidine/spermine Nl-acetyltransferase (SSAT) gene. Biochem. J., 2001, 355, 45-49.
49. Shoji, Y.; Osman, W.; Zilliacus, J. Polyamine-modulated factor 1 represses glucocorticoid receptor activity. Biochem. Biophys. Res. Commun., 2007, 361, 176-181.
50. McGowan, P.O.; Sasaki, A.; DAlessio, A.C.; Dymov, S.; Labonte, B.; Szyf, M.; Turecki, G.; Meaney, M.J. Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse. Nat. Neurosci., 2009, 12, 342-348.
51. Labonte, B.; Yerko, V.; Gross, J; Mechawar, N.; Meaney, M.J.; Szyf, M.; Turecki, G. Differential glucocorticoid receptor exon 7(B), 7(C), and 7(H) expression and methylation in suicide completers with a history of childhood abuse. Biol. Psychiatry, 2012, 72, 41-48.
52. Sokolowski, M.; Ben-Efraim, Y.J.; Wasserman, J.; Wasserman, D. Glutamatergic GRIN2B and polyaminergic ODC1 genes in suicide attempts: associations and gene-environment interactions with childhood/adolescent physical assault. Mol Psychiatry, 2012 [Epub ahead of print].
53. Coleman, C.S.; Stanley, B.A.; Jones, A.D.; Pegg, A.E. Spermidine/spermine-Nl-acetyltransferase-2 (SSAT2) acetylates thialysine and is not involved in polyamine metabolism. Biochem. J., 2004, 384, 139-148.
54. Sequeira, A.; Klempan, T.; Canetti, L.; ffrench-Mullen, J; Benkelfat, C; Rouleau, G.A.; Turecki, G. Patterns of gene expression in the limbic system of suicides with and without major depression. Mol Psychiatry, 2007, 12, 640-655.
55. Fiori, L.M.; Turecki, G Genetic and epigenetic influences on expression of spermine synthase and spermine oxidase in suicide completers. Ml J. Neuropsychopharmacol, 2010, 13, 725-736.
56. Fiori, L.M.; Gross, J.A.; Turecki, G Effects of histone modifications on increased expression of polyamine biosynthetic genes in suicide. Ml J. Neuropsychopharmacol., 2012, 75(8), 1161-1166.
57. Chen, G.G.; Turecki, G; Mamer, O.A. A quantitative GC-MS method for three major polyamines in postmortem brain cortex. J. Mass Spectromet, 2009, 44, 1203-1210.
58. Chen, GG; Turecki, G.; Mamer, O.A. A novel liquid-liquid extraction and stable isotope dilution NCI-GC-MS method for quantitation of agmatine in postmortem brain cortex. J. Mass Spectromet., 2010, 45, 560-565.
59. Chen, G.G.; Fiori, L.M.; Mamer, O.A.; Turecki, G High-resolution capillary gas chromatography in combination with mass speclrometry for quantification of three major polyamines in postmortem brain cortex. Methods Mol Biol, 2011, 720, 427-436.
60. Chen, G.G.; Fiori, L.M.; Moquin, L.; Gratton, A.; Mamer, O; Mechawar, N.; Turecki, G. Evidence of altered polyamine concentrations in cerebral cortex of suicide completers. Neuropsychopharmacology, 2010, 35, 1477-1484.
61. Akbarian, S.; Ruehl, M.G; Bliven, E.; Luiz, L.A.; Peranelli, A.C.; Baker, S.P.; Roberts, RC; Bunney, W.E., Jr.; Conley, RC; Jones, E.G.; Tamminga, C.A.; Guo, Y. Chromatin alterations associated with down-regulated metabolic gene expression in the prefrontal cortex of subjects with schizophrenia. Arch. Gen. Psychiatry, 2005, 62, 829-840.
62. Hobara, T.; Uchida, S.; Otsuki, K.; Matsubara, T.; Funato, H.; Matsuo, K.; Suetsugi, M.; Watanabe, Y. Altered gene expression of histone deacetylases in mood disorder patients. J. Psychiat. Res., 2010, 44, 263-270.
63. McGowan, P.O.; Sasaki, A.; Huang, T.C.; Unterberger, A.; Suderman, M.; Ernst, C; Meaney, M.J.; Turecki, G.; Szyf, M. Promoter-wide hypermethylation of the ribosomal RNA gene promoter in the suicide brain. PloS One, 2008, 3, e2085.
64. Schubeler, D. Epigenomics: Methylation matters. Nature, 2009, 462, 296-297.
65. Elliott, E.; Ezra-Nevo, G; Regev, L.; Neufeld-Cohen, A.; Chen, A. Resilience to social stress coincides with functional DNA methylation of the Crf gene in adult mice. Nat. Neurosci., 2010, 13, 1351-1353.
66. Maunakea, A.K.; Nagarajan, R.P.; Bilenky, M.; Ballinger, T.J.; D'Souza, C; Fouse, S.D.; Johnson, B.E.; Hong C; Nielsen, C; Zhao, Y; Turecki, G.; Delaney, A.; Varhol, R; Thiessen, N.; Shchors, K.; Heine, V.M.; Rowitch, D.H.; Xing X.; Fiore, C; Schillebeeckx, M.; Jones, S.J.; Haussler, D.; Marra, M.A.; Hirst, M.; Wang T.; Costello, J.F. Conserved role of intragenic DNA methylation in regulating alternative promoters. Nature, 2010, 466, 253-257.
67. Song, C.X.; He, C. The hunt for 5-hydroxymethylcytosine: the sixth base. Epigenomics, 2011, 3, 521-523.
68. Tahiliani, M.; Koh, K.P.; Shen, Y.; Pastor, W.A.; Bandukwala, H.; Brudno, Y.; Agarwal, S.; Iyer, L.M.; Liu, D.R; Aravind, L.; Rao, A. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science, 2009, 324, 930-935.
69. Kriaucionis, S.; Heintz, N. The nuclear DNA base 5-hydroxymethylcytosine is present in Purkinje neurons and the brain. Science, 2009, 324, 929-930.
70. Li, W.; Liu, M. Distribution of 5-hydroxymethylcytosine in different human tissues. J. Nucleic Acids, 2011, 2011, 870726.
71. Jin, S.G.; Wu, X.; Li, A.X.; Pfeifer, G.P. Genomic mapping of 5-hydroxymethylcytosine in the human brain. Nucleic Acids Res., 2011, 39, 5015-5024.
72. Chia, N.; Wang, L.; Lu, X.; Senut, M.C.; Brenner, C; Ruden, D.M. Hypothesis: environmental regulation of 5-hydroxymethylcytosine by oxidative stress. Epigenetics, 2011, 6, 853-856.